🇺🇸 FDA
Patent

US 9868961

Methods and compositions for localized secretion of anti-CTLA-4 antibodies

granted A61KA61K2039/505A61P

Quick answer

US patent 9868961 (Methods and compositions for localized secretion of anti-CTLA-4 antibodies) held by The Regents of the University of California expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/505, A61P, A61P35/00, A61P43/00